Breaking
Novo Nordisk Launches Wegovy in China Before Eli Lilly, Capturing World's Largest Obesity MarketVanda Pharmaceuticals Launches NEREUS (Tradipitant) - First New Motion Sickness Drug in 40+ Years Now AvailableTakeda's TAK-881 Meets Primary Endpoint in Phase 2/3 Trial for Primary Immunodeficiency Disease
🇺🇸 FDA

Financial Performance

Page 1 • 0 items

Track global pharma financial performance, M&A deals, and investment trends. Gain critical insights for strategic decision-making in the biopharma sector.

No articles in this category

Check back soon or browse all news.